PXDNL
protein-codingperoxidasin like, the group of I-set domain containing
Gene summary
Predicted to enable heme binding activity and peroxidase activity. Predicted to be involved in hydrogen peroxide catabolic process. Located in cytosol. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~489.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PXDNL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_144651.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 12 | 7 | 21 | ||
| missense | 256 | 20 | 14 | 290 | ||
| nonsense | 2 | 1 | 3 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 0 | 0 | 261 | 32 | 24 | 317 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_653252.4 | 23 | MANE Select | |
| Ensembl | ENSP00000348645.4 | 23 | MANE Select | |
| Ensembl | ENSP00000429855.1 | 4 | Standard | |
| Ensembl | ENSP00000428114.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- response to oxidative stress
- hydrogen peroxide catabolic process
- oxidation-reduction process
- nucleic acid phosphodiester bond hydrolysis
- cellular oxidant detoxification
Molecular Function
- endonuclease activity
- peroxidase activity
- heme binding
- metal ion binding
Cellular Component
- extracellular space
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000356297
- Coding exons
- 23
- Length
- 489868
- Individuals with no LoFs
- 119322
- Homozygous LoFs
- 112
- Heterozygous LoFs
- 5236
- Defined
- 124670
- p
- 0.0217
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.197 | 840 | 824 | 1.02 | 0.0000493 | 9417 |
| Missense (PolyPhen) | 289 | 274.21 | 1.0539 | 3355 | ||
| Synonymous | 1.27 | 310 | 340 | 0.913 | 0.0000229 | 2914 |
| Loss of Function | 0.929 | 58 | 66.2 | 0.877 | 0.00000377 | 733 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.036 | 0.036 | notable |
| Latino/Admixed American | 0.0089 | 0.0088 | notable |
| Ashkenazi Jewish | 0.043 | 0.043 | notable |
| East Asian | 0.0016 | 0.0016 | notable |
| Finnish | 0.0045 | 0.0045 | notable |
| European (Non-Finnish) | 0.017 | 0.016 | notable |
| South Asian | 0.069 | 0.068 | notable |
| Other | 0.017 | 0.016 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Isoform PMR1: Endonuclease selectively degrading some target mRNAs while they are engaged by translating ribosomes, among which albumin and beta-globin mRNAs. {ECO:0000269|PubMed:22543864}.;
Intolerance Scores
- RVIS EVS
- 2.73
- RVIS percentile EVS
- 98.95
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0943
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |